Table 1.
The IC50 and CRs of the three AFB1 mAbs against AFB1 analogs.
| Compounds | 2A11 | 2F6 | 3G2 | |||
|---|---|---|---|---|---|---|
| IC50 (μg/L) a | CR (%) b | IC50 (μg/L) a | CR (%) b | IC50 (μg/L) a | CR (%) b | |
| AFB1 | 6.28 ± 0.41 | 100 | 7.85 ± 0.57 | 100 | 14.36 ± 1.15 | 100 |
| AFB2 | 144.32 ± 11.82 | 4.35 | 168.82 ± 13.17 | 4.65 | 263.97 ± 17.92 | 5.44 |
| AFG1 | 272.81 ± 18.22 | 2.30 | 310.28 ± 21.42 | 2.53 | 469.28 ± 31.08 | 3.06 |
| AFG2 | 690.11 ± 44.86 | 0.91 | 801.02 ±54.44 | 0.98 | 1495.83 ± 95.72 | 0.96 |
| AFM1 | >5000 | <0.1 | >5000 | <0.1 | >5000 | <0.1 |
| AFM2 | >5000 | <0.1 | >5000 | <0.1 | >5000 | <0.1 |
| Zearalenone | >10,000 | <0.1 | >10,000 | <0.1 | >10,000 | <0.1 |
| Deoxynivalenol | >10,000 | <0.1 | >10,000 | <0.1 | >10,000 | <0.1 |
| T-2 toxin | >10,000 | <0.1 | >10,000 | <0.1 | >10,000 | <0.1 |
| Ochratoxin A | >10,000 | <0.1 | >10,000 | <0.1 | >10,000 | <0.1 |
Note: (a) The standard solution was prepared using 70% methanol-PBS (7:3, v/v). (b) The data were calculated using the CR of AFB1 mAbs against AFB1 as 100%.